Covira Surgical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $598K

  • Investors
  • 7

Covira Surgical General Information

Description

Developer of therapeutic alternatives designed to enhance immunity and improve one's overall health risk against infection. The company's therapeutic alternatives leverage the gut microbiome to prevent infection-related postoperative complications without contributing to antibiotic resistance, enabling healthcare providers to treat patients and improve lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3333 Green Bay Road
  • Suite 210, Innovation and Research Park
  • North Chicago, IL 60064
  • United States
+1 (847)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3333 Green Bay Road
  • Suite 210, Innovation and Research Park
  • North Chicago, IL 60064
  • United States
+1 (847)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Covira Surgical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Oct-2023 $598K Completed Pre-Clinical Trials
5. Early Stage VC 06-Sep-2022 Completed Pre-Clinical Trials
4. Equity Crowdfunding 28-Apr-2022 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Jan-2022 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jun-2020 Completed Pre-Clinical Trials
1. University Spin-Out 07-Sep-2018 Completed Startup
To view Covira Surgical’s complete valuation and funding history, request access »

Covira Surgical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Covira Surgical Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Cephalo Ventures Venture Capital Minority
Keiretsu Forum Angel Group Minority
Creative Destruction Lab Accelerator/Incubator Minority
University of Toronto University
You’re viewing 5 of 7 investors. Get the full list »

Covira Surgical FAQs

  • When was Covira Surgical founded?

    Covira Surgical was founded in 2018.

  • Where is Covira Surgical headquartered?

    Covira Surgical is headquartered in North Chicago, IL.

  • What is the size of Covira Surgical?

    Covira Surgical has 6 total employees.

  • What industry is Covira Surgical in?

    Covira Surgical’s primary industry is Drug Discovery.

  • Is Covira Surgical a private or public company?

    Covira Surgical is a Private company.

  • What is Covira Surgical’s current revenue?

    The current revenue for Covira Surgical is .

  • How much funding has Covira Surgical raised over time?

    Covira Surgical has raised $1.28M.

  • Who are Covira Surgical’s investors?

    National Institutes of Health, Cephalo Ventures, Keiretsu Forum, Creative Destruction Lab, and University of Toronto are 5 of 7 investors who have invested in Covira Surgical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process